Biogen’s multiple sclerosis franchise has been handed a boost with the US approval of Vumerity, a follow-up to its blockbuster Tecfidera that promises to be less likely to cause gastrointestinal ...

While multiple sclerosis (MS) can affect anyone, it is estimated that the disease is three times more common in women than in men. MS is an autoimmune disease that attacks the central nervous ...